Continuous processing, already conventional in many manufacturing fields, has been establishing itself in biopharma, which is starting to realize continuous processing’s compelling advantages: ...
Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...
Leveraging biologics manufacturing capacity to supply life-improving or life-saving medicines is key to a flexible supply chain that can respond to unforeseen demand changes. This webinar examines how ...
(At left) The raw materials, culture media, and even the cell lines used to make biopharmaceuticals may contain viruses. If these viruses are not inactivated and removed during drug processing, they ...
Research shows that digital transformation is the primary driver of automation technology spending across the discrete, batch, and continuous process industries. But which technologies get the most ...
SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this particular case, messenger ribonucleic acid (mRNA) encapsulated in lipid ...
DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback